SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-003350
Filing Date
2020-01-14
Accepted
2020-01-14 17:54:26
Documents
2
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1597
2 POA DOCUMENT poa.txt EX-24.3_888706 3094
  Complete submission text file 0001209191-20-003350.txt   6150
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Strauss David Eric (Reporting) CIK: 0001799869 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 20526861